Moelis & Company (NYSE:MC) Posts Quarterly Earnings Results, Beats Expectations By $0.11 EPS

Moelis & Company (NYSE:MC) issued its quarterly earnings results on Wednesday. The asset manager reported $0.22 EPS for the quarter, topping the consensus estimate of $0.11 by $0.11, Briefing.com reports. Moelis & Company had a negative return on equity of 0.13% and a negative net margin of 1.33%. The firm had revenue of $217.49 million during the quarter, compared to analysts’ expectations of $219.30 million. During the same period in the previous year, the business earned $0.05 earnings per share. The firm’s revenue for the quarter was up 17.4% on a year-over-year basis.

Moelis & Company Trading Down 1.0 %

MC opened at $49.75 on Friday. The stock’s 50-day moving average price is $54.07 and its 200 day moving average price is $51.54. Moelis & Company has a 12-month low of $33.87 and a 12-month high of $58.67. The firm has a market cap of $3.54 billion, a price-to-earnings ratio of -261.84 and a beta of 1.35.

Moelis & Company Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 20th. Stockholders of record on Monday, May 6th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 4.82%. The ex-dividend date is Friday, May 3rd. Moelis & Company’s dividend payout ratio (DPR) is presently -1,263.16%.

Insider Buying and Selling

In related news, insider Navid Mahmoodzadegan sold 20,001 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $55.82, for a total transaction of $1,116,455.82. Following the transaction, the insider now owns 79,859 shares of the company’s stock, valued at approximately $4,457,729.38. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In other Moelis & Company news, insider Christopher Callesano sold 1,040 shares of the stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $53.59, for a total value of $55,733.60. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Navid Mahmoodzadegan sold 20,001 shares of the stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $55.82, for a total value of $1,116,455.82. Following the completion of the sale, the insider now directly owns 79,859 shares in the company, valued at approximately $4,457,729.38. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 375,185 shares of company stock valued at $20,130,225. Corporate insiders own 6.96% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. JMP Securities restated a “market perform” rating on shares of Moelis & Company in a report on Tuesday, April 9th. StockNews.com upgraded Moelis & Company from a “sell” rating to a “hold” rating in a report on Thursday, February 8th. Keefe, Bruyette & Woods restated a “market perform” rating and issued a $54.00 target price (down from $58.00) on shares of Moelis & Company in a report on Thursday. JPMorgan Chase & Co. upped their target price on Moelis & Company from $46.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, February 8th. Finally, UBS Group upped their target price on Moelis & Company from $45.00 to $47.00 and gave the company a “sell” rating in a report on Thursday. Two research analysts have rated the stock with a sell rating and five have assigned a hold rating to the stock. According to MarketBeat, Moelis & Company presently has a consensus rating of “Hold” and a consensus price target of $50.80.

Moelis & Company Company Profile

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.